Combination of (a) a phosphoinositide 3-kinase inhibitor and (b) a modulator of Ras/Raf/Mek pathway

Details for Australian Patent Application No. 2009268469 (hide)

Owner Novartis AG

Inventors Nagel, Tobi; Garcia-Echeverria, Carlos; Fritsch, Christine; Stuart, Darrin; Wee, Susan; Maira, Sauveur-Michel

Agent Davies Collison Cave

Pub. Number AU-A-2009268469

PCT Pub. Number WO2010/006225

Priority 08160218.7 11.07.08 EP

Filing date 10 July 2009

Wipo publication date 14 January 2010

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/4188 (2006.01)

Event Publications

27 January 2011 PCT application entered the National Phase

  PCT publication WO2010/006225 Priority application(s): WO2010/006225

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009268471-Field terminable fiber optic connector assembly

2009268467-Water screen belt module